In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines.

For IRA specific questions, please reach out to [email protected]. If you have any other questions for our guests, or suggestions for future topics, email us at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms.

If you have questions for our guests, or suggestions for future topics, email us at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers.

If you have questions for our guests, or suggestions for future topics, email us at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical Officer, who will discuss operationalizing in practice from a provider perspective.

If you have questions for our guests, or suggestions for future topics, email us at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a pharmacist perspective.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's ION Oncology Network East Region, discuss billing and reimbursement of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New Business Development for Cencora's SAN GPO National Accounts, who will discuss the landscape and pipeline of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in MedicoCX practices.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.

In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill.
 
 To find a copy of Kortney's presentation, please visit our OnCall page under Clinical Education on our ION and Specialty Practice Network websites.

If you have questions for our guests or suggestions for future topics, send us an email at [email protected].

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.